FDA approves Takeda's Orzeyful for narcolepsy type 1 in adults

August 5, 2026 6:10 PM

Takeda (TSE: 4502 / NYSE: TAK) announced that the U.S. Food and Drug Administration has approved Orzeyful (oveporexton), an oral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found